Clik here to view.
Bill Ackman is acting a lot like he did the last time he blew up a hedge fund
Part of why history repeats itself so often is that it's so rare for grown people to change, especially if they are Masters of the Universe accustomed to being right.It is with that in mind that we...
View ArticleClik here to view.
Bill Ackman just cut back on his biggest bet
Bill Ackman, the founder of $12 billion Pershing Square, has sold a big portion of his Mondelez stake.Pershing Square sold 20 million shares, and now has a 5.6% stake in the maker of Oreos and Sour...
View ArticleClik here to view.
Bill Ackman is having the worst year in his fund's history (VRX, HHC, HLF,...
Hedge fund billionaire Bill Ackman, founder of $12 billion Pershing Square Capital, is having the worst year in his fund's history.Pershing Square Holdings, his fund's publicly traded vehicle, has...
View ArticleClik here to view.
Valeant is getting hammered, again (VRX)
The embattled Canadian drug company Valeant Pharmaceuticals is getting hammered again. Valeant's stock fell below $30 on Thursday, hitting a 52-week low of $29.88. Valeant's share price was last...
View ArticleClik here to view.
Valeant CEO sends memo to employees assuring them the company isn't on the...
Valeant CEO Mike Pearson sent a memo to the company's employees on Wednesday assuring them that, among other things, the company wasn't on the verge of filing for bankruptcy, according to a report from...
View ArticleClik here to view.
Valeant is looking for a new CEO and has named Bill Ackman to the board (VRX)
The embattled Canadian drug company Valeant Pharmaceuticals is ousting its CEO, Michael Pearson. Pearson will remain until a successor is named.Activist investor Bill Ackman is joining the company's...
View ArticleClik here to view.
Valeant is now The Bill Ackman Show, and here's the next act
Everything that happens at Valeant Pharmaceuticals from this moment on will come from Bill Ackman.As of Monday morning he has a seat on the board, in addition to connections to three other board...
View ArticleClik here to view.
Bill Ackman’s plan to fix Valeant is doomed
Valeant Pharmaceuticals is frozen.Until the company replaces the two years worth of earnings numbers that it scrapped due to admitted accounting issues on Monday, its value could be considered a matter...
View ArticleClik here to view.
Bill Ackman's hedge fund is cooperating with an investigation into...
BOSTON (Reuters) - Billionaire investor William Ackman, whose hedge fund is one of the biggest investors in drug company Valeant, has been asked to supply information to U.S. legislators probing price...
View ArticleClik here to view.
You can now enter Wall Street's biggest investment contest of the year
The Sohn Conference's famed investment idea contest officially kicks off today.The contest is open to anyone with a long or short idea for a company with a market cap above $1 billion. The deadline to...
View ArticleClik here to view.
The government is pushing back against a merger Bill Ackman has been after...
The head of the House Transportation and Infrastructure Committee has expressed his opposition to a merger between railroad companies Norfolk Southern and Canadian Pacific.The takeover of Norfolk...
View ArticleClik here to view.
'We've made a number of mistakes in Valeant that have required some...
Bill Ackman, founder of the $12 billion hedge fund Pershing Square Capital, just finished a conference call in which he answered investors' questions.Ackman is having the worst year in his fund's...
View ArticleClik here to view.
Monday's failed megamerger is an even bigger deal than it looks
The months-long pursuit of the regional railroad giant Norfolk Southern by Canadian Pacific Railway abruptly ended Monday.It was the second scuttled merger attempt by CP in two years.Many of the...
View ArticleClik here to view.
Bill Ackman goes to Congress
Hedge fund billionaire Bill Ackman will testify before the US Senate on Wednesday and answer questions about his relationship with Valeant Pharmaceuticals.Ackman sits on the board of the embattled...
View ArticleClik here to view.
Bill Ackman's Valeant losses might've caused him to unload a sizable portion...
Bill Ackman’s Pershing Square has unloaded a sizable stake in Canadian Pacific Railway Limited (NYSE:CP), and losses from its Valeant Pharmaceuticals position are being blamed. The activist investor...
View ArticleClik here to view.
Elizabeth Warren gets a go at hedge fund billionaire Bill Ackman
Hedge fund billionaire Bill Ackman will testify before the US Senate Special Committee on Aging on Wednesday.He's been called to speak about one of his major investments, Valeant Pharmaceuticals, and...
View ArticleClik here to view.
The prepared statements from Valeant's Senate hearing are already making us...
A US Senate hearing on Valeant Pharmaceuticals is underway, and just based on the prepared statements we've reviewed, we can tell it's going to be a roller coaster.Valeant CEO Michael Pearson, former...
View ArticleClik here to view.
Bill Ackman and Valeant execs just got through one of the most brutal Senate...
Valeant Pharmaceuticals' outgoing CEO, Mike Pearson, the company's former interim CEO, Howard Schiller, and board member and hedge fund billionaire Bill Ackman all just testified before the US...
View ArticleClik here to view.
Valeant is making huge changes to its board
Drugmaker Valeant Pharmaceuticals is expected to name four new directors as soon as Friday, The Wall Street Journal reported.Five of its long-standing directors have agreed to step down to make room...
View ArticleClik here to view.
The new Valeant CEO's pay package is putting the company in serious danger
If you blinked, you may have missed it — a lot of politicians did.It's the part of incoming Valeant Pharmaceuticals CEO Joe Papa's pay package that makes it a dangerous deal.Bloomberg reported...
View Article